Opinion|Videos|July 15, 2024
Hidradenitis Suppurativa (HS): Staging Considerations and Unmet Needs
Author(s)Vivian Shi, MD, FAAD
An expert on hidradenitis suppurativa (HS) provides an overview of the Hurley staging system and discusses unmet needs in the overall treatment landscape.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- How does current treatment of HS correlate to the Hurley staging system?
- What are the unmet needs for the treatment of HS?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment
2
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
3
Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations
4
New Dermatologic Therapies Make Waves at Maui Derm 2026
5
